Most Read Articles
Roshini Claire Anthony, Yesterday

The addition of methylprednisolone to standard care* reduced mortality risk in patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF), according to a study from China.

05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.

Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Stephen Padilla, 22 Feb 2021
Treatment with intravenous (IV) dexamethasone for 10 days significantly reduces duration of mechanical ventilation at 28 days and 60-day mortality in patients with established moderate-to-severe acute respiratory disease syndrome (ARDS) compared with no dexamethasone, results of the DEXA-ARDS trial have shown.

Product Highlight - Forxiga

26 Jun 2020

In DECLARE TIMI-58:
Forxiga has shown to provide early CARDIORENAL benefits beyond HbA1c reduction in T2DM patients across CV risks1,2,3

  • Reduce the risk of hospitalization for heart failure compared to placebo by 27%.1
  • Reduce the risk of progression to nephropathy compared to placebo by 47%.2^
  • Well established safety profile compared to placebo.1,2
  • Superior reduction of glycaemic control compared to DPP4i with additional benefit of weight loss and BP reduction.3,4*

^Forxiga is not indicated for the treatment of heart failure and chronic kidney disease.
* Forxiga is not indicated for the management of weight loss or high blood pressure. Weight change was a secondary endpoint in clinical trials. Blood pressure change was primarily assessed as a safety or exploratory endpoint.


References:
1. Wiviott SD et.al. N Engl J Med. 2019; 380(4):347-357.
2. Mosenzon O et.al. The Lancet Diabetes & Endocrinology 2019 Aug 7(8):606-617.
3. Rosenstock J, et al. Presented at WCIRDC 2016 Poster 99.
4. Rosenstock J et.al. Arch Endocrinol Metab. 2018;62(4):424-430.


Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, Yesterday

The addition of methylprednisolone to standard care* reduced mortality risk in patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF), according to a study from China.

05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.

Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Stephen Padilla, 22 Feb 2021
Treatment with intravenous (IV) dexamethasone for 10 days significantly reduces duration of mechanical ventilation at 28 days and 60-day mortality in patients with established moderate-to-severe acute respiratory disease syndrome (ARDS) compared with no dexamethasone, results of the DEXA-ARDS trial have shown.